Cargando…

A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION

PURPOSE: The LIGHTSITE I study investigated the efficacy and safety of photobiomodulation (PBM) treatment in subjects with dry age-related macular degeneration. METHODS: Thirty subjects (46 eyes) were treated with the Valeda Light Delivery System, wherein subjects underwent two series of treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Markowitz, Samuel N., Devenyi, Robert G., Munk, Marion R., Croissant, Cindy L., Tedford, Stephanie E., Rückert, Rene, Walker, Michael G., Patino, Beatriz E., Chen, Lina, Nido, Monica, Tedford, Clark E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392581/
https://www.ncbi.nlm.nih.gov/pubmed/31404033
http://dx.doi.org/10.1097/IAE.0000000000002632
_version_ 1783564874247307264
author Markowitz, Samuel N.
Devenyi, Robert G.
Munk, Marion R.
Croissant, Cindy L.
Tedford, Stephanie E.
Rückert, Rene
Walker, Michael G.
Patino, Beatriz E.
Chen, Lina
Nido, Monica
Tedford, Clark E.
author_facet Markowitz, Samuel N.
Devenyi, Robert G.
Munk, Marion R.
Croissant, Cindy L.
Tedford, Stephanie E.
Rückert, Rene
Walker, Michael G.
Patino, Beatriz E.
Chen, Lina
Nido, Monica
Tedford, Clark E.
author_sort Markowitz, Samuel N.
collection PubMed
description PURPOSE: The LIGHTSITE I study investigated the efficacy and safety of photobiomodulation (PBM) treatment in subjects with dry age-related macular degeneration. METHODS: Thirty subjects (46 eyes) were treated with the Valeda Light Delivery System, wherein subjects underwent two series of treatments (3× per week for 3–4 weeks) over 1 year. Outcome measures included best-corrected visual acuity, contrast sensitivity, microperimetry, central drusen volume and drusen thickness, and quality of life assessments. RESULTS: Photobiomodulation-treated subjects showed a best-corrected visual acuity mean letter score gain of 4 letters immediately after each treatment series at Month 1 (M1) and Month 7 (M7). Approximately 50% of PBM-treated subjects showed improvement of ≥5 letters versus 13.6% in sham-treated subjects at M1. High responding subjects (≥5-letter improvement) in the PBM-treated group showed a gain of 8 letters after initial treatment (P < 0.01) and exhibited earlier stages of age-related macular degeneration disease. Statistically significant improvements in contrast sensitivity, central drusen volume, central drusen thickness, and quality of life were observed (P < 0.05). No device-related adverse events were reported. CONCLUSION: Photobiomodulation treatment statistically improved clinical and anatomical outcomes with more robust benefits observed in subjects with earlier stages of dry age-related macular degeneration. Repeated PBM treatments are necessary to maintain benefits. These pilot findings support previous reports and suggest the utility of PBM as a safe and effective therapy in subjects with dry age-related macular degeneration.
format Online
Article
Text
id pubmed-7392581
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Retina
record_format MEDLINE/PubMed
spelling pubmed-73925812020-08-14 A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION Markowitz, Samuel N. Devenyi, Robert G. Munk, Marion R. Croissant, Cindy L. Tedford, Stephanie E. Rückert, Rene Walker, Michael G. Patino, Beatriz E. Chen, Lina Nido, Monica Tedford, Clark E. Retina Original Study PURPOSE: The LIGHTSITE I study investigated the efficacy and safety of photobiomodulation (PBM) treatment in subjects with dry age-related macular degeneration. METHODS: Thirty subjects (46 eyes) were treated with the Valeda Light Delivery System, wherein subjects underwent two series of treatments (3× per week for 3–4 weeks) over 1 year. Outcome measures included best-corrected visual acuity, contrast sensitivity, microperimetry, central drusen volume and drusen thickness, and quality of life assessments. RESULTS: Photobiomodulation-treated subjects showed a best-corrected visual acuity mean letter score gain of 4 letters immediately after each treatment series at Month 1 (M1) and Month 7 (M7). Approximately 50% of PBM-treated subjects showed improvement of ≥5 letters versus 13.6% in sham-treated subjects at M1. High responding subjects (≥5-letter improvement) in the PBM-treated group showed a gain of 8 letters after initial treatment (P < 0.01) and exhibited earlier stages of age-related macular degeneration disease. Statistically significant improvements in contrast sensitivity, central drusen volume, central drusen thickness, and quality of life were observed (P < 0.05). No device-related adverse events were reported. CONCLUSION: Photobiomodulation treatment statistically improved clinical and anatomical outcomes with more robust benefits observed in subjects with earlier stages of dry age-related macular degeneration. Repeated PBM treatments are necessary to maintain benefits. These pilot findings support previous reports and suggest the utility of PBM as a safe and effective therapy in subjects with dry age-related macular degeneration. Retina 2020-08 2019-08-09 /pmc/articles/PMC7392581/ /pubmed/31404033 http://dx.doi.org/10.1097/IAE.0000000000002632 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Opthalmic Communications Society, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Study
Markowitz, Samuel N.
Devenyi, Robert G.
Munk, Marion R.
Croissant, Cindy L.
Tedford, Stephanie E.
Rückert, Rene
Walker, Michael G.
Patino, Beatriz E.
Chen, Lina
Nido, Monica
Tedford, Clark E.
A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
title A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
title_full A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
title_fullStr A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
title_full_unstemmed A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
title_short A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
title_sort double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392581/
https://www.ncbi.nlm.nih.gov/pubmed/31404033
http://dx.doi.org/10.1097/IAE.0000000000002632
work_keys_str_mv AT markowitzsamueln adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT devenyirobertg adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT munkmarionr adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT croissantcindyl adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT tedfordstephaniee adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT ruckertrene adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT walkermichaelg adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT patinobeatrize adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT chenlina adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT nidomonica adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT tedfordclarke adoublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT markowitzsamueln doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT devenyirobertg doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT munkmarionr doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT croissantcindyl doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT tedfordstephaniee doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT ruckertrene doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT walkermichaelg doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT patinobeatrize doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT chenlina doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT nidomonica doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration
AT tedfordclarke doublemaskedrandomizedshamcontrolledsinglecenterstudywithphotobiomodulationforthetreatmentofdryagerelatedmaculardegeneration